Hydroxyurea toxicity in human immunodeficiency virus-positive patients.
Goodrich
J
J
Southern Illinois University School of Medicine, Springfield 62794-1311, USA. jgoodrich@siumed.edu
Khardori
N
N
D000328:Adult; D001853:Bone Marrow / Q000187:drug effects* / Q000473:pathology; D004305:Dose-Response Relationship, Drug; D004791:Enzyme Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D005500:Follow-Up Studies; D015658:HIV Infections / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D018451:Homosexuality, Male; D006801:Humans; D006918:Hydroxyurea / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male
D004791:Enzyme Inhibitors; D006918:Hydroxyurea